Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on selective fluorination. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel regioselective process for 5-fluoro-1H-pyrazoles. High purity, scalable agrochemical intermediate manufacturing with reduced waste and cost efficiency.
Patent CN101628927A details a stereoselective route for Gemcitabine. Discover cost reduction in pharmaceutical manufacturing and high-purity oncology intermediates.
Patent CN1228342C details a novel route for Gemcitabine using 1,6-dehydro-beta-D-glucose, offering improved stereoselectivity and cost reduction in API manufacturing.
Patent CN107245023B introduces stable imidosulfinyl fluoride reagents enabling safe cost reduction in pharmaceutical intermediates manufacturing with high stereoselectivity.
Patent CN112457277B reveals a high-yield route for Tafluprost intermediates, optimizing fluorination timing to eliminate side reactions and reduce manufacturing costs.
Novel green route for Abemaciclib intermediate using Selectfluor. Eliminates Palladium residues and reduces costs. Ideal for API manufacturing scale-up.
Novel hydrolysis route for 2-(trifluoromethyl)benzaldehyde offers high purity and industrial scalability for pharma intermediates.
Patent CN108070012B details selective synthesis. Offers high purity and scalable production for corticosteroid supply chains.
Novel selective synthesis method for 6α-fluoro tetraene acetate intermediates. Reduces isomers, enhances supply chain reliability for corticosteroid manufacturing.
Patent CN117326961A offers safer route avoiding cyanide. Reduces cost and improves supply chain reliability for pharmaceutical intermediates manufacturing globally.
Solve supply chain risks and low yields in anticancer intermediate production. Discover a 4-step, 84% yield route using common raw materials. Contact us for scalable CDMO solutions.